Abstract:4156 Background: The hedgehog pathway plays a critical role in embryonic development, tissue polarity and carcinogenesis. It is estimated that activation of this pathway is associated with almost all basal cell carcinomas and in nearly 30% of non-skin cancers. Whereas mutations of human homologue of patched 1 (PTCH1), smoothened (SMO) or suppressor of fused [Su(Fu)] contribute to the development of BCCs and medulloblastomas, whereas elevated expression of the ligands- hedgehog molecules may be responsible for activation of hedgehog signaling in prostate, breast, lung and gastrointestinal cancers. However, the molecular basis for SMO signaling regulation, the essential event in pathway activation, remains unclear. Therefore, identification of novel regulators of SMO will further our understanding of hedgehog-mediated carcinogenesis. Results: Through yeast two hybrid screening using SMO as bait, we identified a Smooothened Interacting Protein, SIP. In cultured cells, we showed that SIP co-immunoprecipitated reciprocally with SMO. Using GST pull-down studies, we showed that the cytoplasmic tail of SMO is responsible for the interaction with SIP. We found that stability of SMO protein, but not Gli1 protein, can be enhanced with ectopic expression of SIP in a dose-dependent manner. To demonstrate whether inactivation of SIP is sufficient to inhibit growth of cancer cells with activated hedgehog signaling, we treated cancer cell lines with SIP siRNA or control siRNA and measured DNA synthesis and softagar growth. We found that SIP siRNA inhibited DNA synthesis and softagar growth of PLC/PRF/5 cells, which have activated hedgehog signaling, but had no effects on HepG2 cells, which have no detectable hedgehog signaling. Conclusion: We have identified a novel regulator of SMO, SIP. We find that SMO interacts with SIP through its c-terminal tail. The protein stability of SMO is enhanced by the presence of SIP. Inactivation of SIP by specific siRNA, just like SMO antagonist cyclopamine, reduced DNA synthesis and cell growth of cancer cells with activated hedgehog signaling. Thus, targeted inhibition of SIP may have significant implications in cancer therapeutics.

Response To Inhibition Of Smoothened In Diverse Epithelial Cancer Cells That Lack Smoothened Or Patched 1 Mutations

Novel-smoothened Inhibitors for Therapeutic Targeting of Naïve and Drug-Resistant Hedgehog Pathway-Driven Cancers.

Identification of a Novel Regulator for Smoothened Signaling in Human Cancers

Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers

Hedgehog signaling controls cytotoxic T cell migration in the tumour microenvironment.

GPCR-like Signaling Mediated by Smoothened Contributes to Acquired Chemoresistance Through Activating Gli.

Cyclopamine Blocked the Growth of Colorectal Cancer SW116 Cells by Modulating Some Target Genes of Gli1 in Vitro

Effects of Inhibition of Hedgehog Signaling on Cell Growth and Migration of Uveal Melanoma Cells.

Discovery of Potent and Novel Smoothened Antagonists Via Structure-Based Virtual Screening and Biological Assays.

Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo

Hedgehog Signaling Pathway Regulates Growth of Human Digestive Tract Tumor Cells

CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists.

Small Molecule Antagonists in Distinct Binding Modes Inhibit Drug-Resistant Mutant of Smoothened.

Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance

Eexpression and Significance of Ptch and Smo in the Tongue Cancinoma Tca8113 Cell lines

Smoothened Antagonist GDC-0449 (vismodegib) Inhibits Proliferation and Triggers Apoptosis in Colon Cancer Cell Lines.

<i>Smo</i> expression at diagnosis predicts prognosis in resected gastrointestinal stromal tumor patients and correlates to imatinib-resistance

Effect of Mutations on Drug Resistance of Smoothened Receptor Toward Inhibitors Probed by Molecular Modeling

Pyrvinium attenuates Hedgehog signaling downstream of smoothened

Strategies to target the Hedgehog signaling pathway for cancer therapy

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance